Sutter's Prices 'Difficult To Justify,' Antitrust Jury Hears
By Bonnie Eslinger · February 15, 2022, 10:05 PM EST
A California federal jury considering a $411 million antitrust class action against Sutter Health heard videotaped testimony Tuesday from a former Sutter vice president who told higher-ups in 2011 that inconsistent...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login